- You are here:
- Home »
- Sitemap
Sitemap
- Products
- About us
- Press & News
- Eurocor at LINC 2018
- Visit our Exhibition Stand #13 at the GulfPCR
- Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen on Sept. 18, 2017
- CIRSE 2017 in Copenhagen
- Eurocor in Paris: EuroPCR 2017
- Visit our Exhibition Stand #31 at CICE Congress 2017
- Eurocor announces the completion of the Freeway Stent Study
- LINC 2017
- IROS 2017
- Visit our Exhibition Stand #12 at the GulfPCR
- Eurocor enters the market with their FREEWAY™ COATED SHUNT BALLOON CATHETER
- Eurocor in Barcelona: CIRSE 2016
- Eurocor FREEWAY™ – COATED SHUNT BALLOON CATHETER launch
- Results of DEBIFU registry are presented during EuroPCR
- Eurocor in Paris: EuroPCR 2016
- Eurocor Receives CE Mark Approval for E-Magic Plus™ SES
- Eurocor participates to LINC Congress in Leipzig (Germany)
- Eurocor launches APERTUS Aspiration Catheter
- Interim Results of the Freeway Stent Study presented at TCT 2013
- Eurocors Valentines Trial II published in EuroIntervention
- Eurocor’s partner - Micell Technologies Receives CE Mark Approval for MiStent SES
- Eurocor Enters into Licensing Agreement with Biosensors for Drug-eluting Balloon Range
- Eurocor Abstracts ranked and honored at CRT Congress 2013
- Eurocor to be present at CRT Congress in Washington DC (USA)
- Eurocor to be present at Arab Health congress, Dubai (United Arabian Emirates)
- Eurocor participates LINC Congress in Leipzig (Germany)
- Eurocor announces interim results of the Freeway™ Stent Study at IROS Congress
- Eurocor to present interim results of Freeway Stent Study at IROS Congress
- Eurocor’s DEBIFU Registry successfully enrolled first patients
- Eurocor participates CIRSE Congress in Lisbon
- Results from the DiabEtic Argentina Registry (DEAR) published ahead of print in Cardiovascular Revascularization Medicine Journal
- Opto Circuits launches its first Sirolimus Drug Eluting Stent
- Eurocor supports Sailing Trip for children with heart diseases
- Eurocor to be present at SOLACI Congress, Mexico City
- Valentines Trial II results presented at EuroPCR 2012 in Paris
- Eurocor announces presentation of Valentines Trial II results at CRT2012
- Eurocor announces first insights of the Freeway Stent Study at LINC Congress
- JIM Joint Interventional Meeting 2012
- CRT Cardiovascular Research Technologies 2012
- Eurocor announces treatment of First Patients in International Randomized Freeride Study
- LINC - Leipzig Interventional Course
- Eurocor is present at IROS Congress
- There is no time more fitting to say thank you
- DIOR® DEB shows remarkable performance in diabetics
- Dr. Antonino Laudani Joins Eurocor GmbH as Chief Operating Officer
- Eurocor with new Distributor in the UK and Ireland
- Eurocor is present on the the 32nd National Congress of the Italian Society of Invasive Cardiology (GISE)
- Eurocor is taking part at the 66° Congresso Brasileiro de Cardiologia, Porto Alegre, Brazil
- Successful Eurocor symposium about drug-eluting balloons at CIRSE in Munich
- Eurocor launches FREEWAY™ DEB in Venezuela
- Eurocors Valentines Trial published in EuroIntervention
- Eurocor is taking part at the Great Wall International Congress of Cardiology in Beijing, China
- Eurocor is present on the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
- Micell Technologies completes enrolment in DESSOLVE II study
- Eurocor allows sailing trip for children with heart disease
- Eurocor is present on the annual meeting of the Swiss Society for Cardiology (SGK)
- DIOR® DEB shows remarkable performance in diabetics with coronary lesions
- Eurocor is present on the "Röntgenkongress" in Hamburg
- Eurocor’s partner Micell reported data for MiStentTM DES
- Eurocor had a successful presence at EuroPCR 2011 in Paris
- Eurocor presented 12 months outcomes of Spanish Registry on the occasion of EuroPCR in Paris
- Eurocor in Paris: EuroPCR 2011
- Eurocor GmbH today announced the launch of DIOROCT Trial with PI Prof. Patrick W. Serruys
- Final data of Valentines Trial I
- Eurocor GmbH announces Study results of Valentines Trial I
- Eurocor launched Magical in India
- Valentines Trial II
- Eurocor Steps Up Research Activities
- LINC - The Leipzig Interventional Course
- Eurocor participates IROS Congress, January 13 - 15 2011
- Eurocor launches FREEWAY
- Eurocor at CACI-TCT, Argentina
- Eurocor participates SAINT Congress, September 10 - 11, 2010
- Eurocor participates TCT Conference, September 21 - 25, 2010
- Eurocor presented successful symposium at SOLACI
- Eurocor completes successful trade-fair appearance at SOLACI
- Eurocor successfully presents Drug Eluting Balloon DIOR to Asian cardiologists
- DIOR catheter: early success in Canada
- Eurocor: Convincing initial results in the DIOR Debiut study
- Eurocor completes successful trade-fair appearance in Paris
- EuroPCR 2010: Press release
- Eurocor in Paris: EuroPCR 2011
- The Valentines Trial - Enrolment finished
- Interims results of “DIOR – the Spanish registry”
- The Spanish Multicenter Registry
- Patient Enrollment for the Valentines Trial
- Eurocor at EuroPCR 2009
- The first-in-man aortic valvuloplasty with a drug-eluting balloon
- Eurocor launches DIOR at the JIM 2007 successfully.
- Contact & Locations